In conclusion, this study reveals a subset of NK cells with high expression of PD-1 in the blood of the patients with lung cancer, and the abundant of these PD-1+ NK cells may be related to the increased concentration of IL-2 in the plasma of the patients. Here, PDCD1 is linked to lung carcinoma.